SPARTA clinical trial design: Exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency
Under a Creative Commons license
open access
Keywords
Alpha1-antitrypsin deficiency
Alpha1-proteinase inhibitor
Prolastin-C
Chronic obstructive pulmonary disease
SPARTA
CT densitometry
Cited by (0)
Copyright © 2015 The Authors. Published by Elsevier Ltd.